News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,677 Results
Type
Article (40034)
Company Profile (258)
Press Release (648385)
Section
Business (206121)
Career Advice (1992)
Deals (35753)
Drug Delivery (79)
Drug Development (80912)
Employer Resources (167)
FDA (16230)
Job Trends (14906)
News (347441)
Policy (32736)
Tag
Academia (2572)
Africa (728)
Alliances (49887)
Alzheimer's disease (1172)
Approvals (16167)
Arizona (176)
Artificial intelligence (78)
Asia (37615)
Australia (6144)
Bankruptcy (354)
Best Places to Work (11398)
Biosimilars (65)
Biotechnology (179)
C2C Services and Suppliers (81425)
California (2041)
Canada (981)
Cancer (567)
Career advice (1662)
Cell therapy (136)
China (164)
Clinical research (63544)
Collaboration (174)
Colorado (85)
Compensation (92)
Connecticut (82)
COVID-19 (2519)
Cystic fibrosis (79)
Data (448)
Diabetes (91)
Diagnostics (6363)
Drug pricing (70)
Earnings (84449)
Employer resources (142)
Europe (81074)
Events (109216)
Executive appointments (169)
FDA (16513)
Florida (294)
Funding (172)
Gene therapy (100)
Georgia (69)
GLP-1 (521)
Government (4344)
Healthcare (18810)
Hotbed/Location (485548)
Illinois (272)
Indiana (153)
Infectious disease (2554)
Inflammatory bowel disease (93)
Interviews (309)
IPO (16360)
Job creations (3679)
Job search strategy (1426)
Kansas (95)
Layoffs (399)
Legal (7884)
Lung cancer (120)
Manufacturing (99)
Maryland (423)
Massachusetts (1650)
Medical device (13203)
Medtech (13208)
Mergers & acquisitions (19280)
Metabolic disorders (269)
Michigan (126)
Minnesota (226)
Neuroscience (1352)
New Jersey (628)
New York (639)
NextGen Class of 2024 (6526)
Non-profit (4513)
North Carolina (633)
Northern California (886)
Obesity (163)
Ohio (111)
Opinion (173)
Patents (78)
Pennsylvania (611)
People (56551)
Phase I (19680)
Phase II (27983)
Phase III (20913)
Pipeline (127)
Postmarket research (2553)
Preclinical (8364)
Press Release (66)
Radiopharmaceuticals (237)
Rare diseases (151)
Real estate (5975)
Regulatory (21509)
Research institute (2345)
Resumes & cover letters (349)
South America (1107)
Southern California (832)
Startups (3640)
Texas (264)
United States (9176)
Vaccines (487)
Washington State (261)
Weight loss (135)
Date
Today (111)
Last 7 days (620)
Last 30 days (2527)
Last 365 days (37198)
2024 (27188)
2023 (40430)
2022 (51549)
2021 (56107)
2020 (54587)
2019 (46975)
2018 (35405)
2017 (32526)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26921)
2012 (29106)
2011 (29799)
2010 (27788)
688,677 Results for "bracco diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Bracco Diagnostics Inc. Announces Update on Product Portfolio
July 9, 2024
·
8 min read
Pharm Country
Bracco Diagnostics Showcases Innovation and Collaborative Vision at RSNA 2023 Annual Meeting
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic imaging, is showcasing its commitment to innovation and purpose-driven partnership at the Radiological Society of North America (RSNA) 2023 Annual Meeting, to be held November 26-30 in Chicago, Illinois.
October 16, 2023
·
8 min read
Bracco Imaging S.p.A. Announces Global Agreement With Subtle Medical, Inc.
Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence -powered image acquisition, have entered into a global agreement in the field of magnetic resonance imaging.
September 21, 2023
·
3 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Business
Olympus Announces Exclusive U.S. Co-Marketing Agreement with Bracco Diagnostics, Inc.
Olympus announced a strategic co-marketing agreement with Monroe Township, N.J.-based Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business.
May 19, 2022
·
4 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Business
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the full year ended December 31, 2023.
March 14, 2024
·
11 min read
Business
Bracco Elevates Next Generation of Radiologists, Announces Recipients of the 2022 “Leaders on the Horizon” Residency Program
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., an innovative world leader in diagnostic imaging, announced the 2022 “Leaders on the Horizon” Residency Program recipients.
November 9, 2022
·
3 min read
1 of 68,868
Next
